Compare Stocks → “The Stock Market’s Bull Run is Far from Over” -Barrons (From Vertical Research Advisory) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:ABNAFOTCMKTS:AGGFFOTCMKTS:ALIAFNASDAQ:CDT Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABNAFAben Minerals$0.06+18.9%$0.06$0.05▼$0.13N/AN/A6,290 shs1,000 shsAGGFFToubani Resources$0.00$0.00$0.00▼$0.19N/AN/A9,178 shsN/AALIAFAlacer Gold$7.27+0.3%$7.27$2.36▼$8.20N/AN/A39,466 shs800 shsCDTConduit Pharmaceuticals$3.67+2.8%$2.99$0.95▼$25.00$267.23M2.3542,759 shs33,077 shs7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABNAFAben Minerals+24.55%+3.28%+25.80%-9.50%-29.33%AGGFFToubani Resources0.00%0.00%0.00%0.00%-99.73%ALIAFAlacer Gold0.00%0.00%0.00%0.00%0.00%CDTConduit Pharmaceuticals+2.80%+6.38%+23.57%-19.34%+366,999,900.00%Did you make $29,000 two days with AI options trades? (Ad)What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:Click Here To Get Your Free CopyMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABNAFAben MineralsN/AN/AN/AN/AN/AN/AN/AN/AAGGFFToubani ResourcesN/AN/AN/AN/AN/AN/AN/AN/AALIAFAlacer GoldN/AN/AN/AN/AN/AN/AN/AN/ACDTConduit PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABNAFAben MineralsN/AN/AN/AN/AAGGFFToubani ResourcesN/AN/AN/AN/AALIAFAlacer GoldN/AN/AN/AN/ACDTConduit PharmaceuticalsN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABNAFAben MineralsN/AN/AN/AN/AN/AN/AAGGFFToubani ResourcesN/AN/AN/AN/AN/AN/AALIAFAlacer GoldN/AN/AN/AN/AN/AN/ACDTConduit PharmaceuticalsN/AN/A$0.10 per share36.33($1.06) per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABNAFAben MineralsN/A-$0.02N/A∞N/AN/AN/AN/A5/26/2024 (Estimated)AGGFFToubani ResourcesN/AN/A0.00∞N/AN/AN/AN/AN/AALIAFAlacer GoldN/AN/A0.00∞N/AN/AN/AN/AN/ACDTConduit Pharmaceuticals$400KN/A0.00∞N/AN/A-82.43%7.08%4/1/2024 (Estimated)DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABNAFAben MineralsN/AN/AN/AN/AN/AAGGFFToubani ResourcesN/AN/AN/AN/AN/AALIAFAlacer GoldN/AN/AN/AN/AN/ACDTConduit PharmaceuticalsN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABNAFAben MineralsN/AN/AN/AAGGFFToubani ResourcesN/AN/AN/AALIAFAlacer GoldN/AN/AN/ACDTConduit PharmaceuticalsN/A2.272.27OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABNAFAben Minerals0.21%AGGFFToubani ResourcesN/AALIAFAlacer GoldN/ACDTConduit Pharmaceuticals3.29%Insider OwnershipCompanyInsider OwnershipABNAFAben MineralsN/AAGGFFToubani ResourcesN/AALIAFAlacer GoldN/ACDTConduit Pharmaceuticals23.49%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableABNAFAben MineralsN/AN/AN/ANot OptionableAGGFFToubani Resources201N/AN/ANot OptionableALIAFAlacer Gold691N/AN/ANot OptionableCDTConduit PharmaceuticalsN/A72.81 million55.71 millionNot OptionableCDT, ABNAF, AGGFF, A1M, and ALIAF HeadlinesSourceHeadlineConduit Pharma names Joanne Holland as CSOthepharmaletter.com - March 20 at 6:16 PMConduit Pharmaceuticals Adds Key Leadership Positionsfinance.yahoo.com - March 19 at 2:06 PMConduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officerglobenewswire.com - March 19 at 7:00 AMShort Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Decreases By 39.1%marketbeat.com - March 14 at 8:44 PMConduit Pharmaceuticals Opens New Laboratory in UKfinance.yahoo.com - March 11 at 6:13 PMConduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hubfinance.yahoo.com - March 11 at 7:45 AMConduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hubglobenewswire.com - March 11 at 7:00 AMShort Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Declines By 13.2%marketbeat.com - March 3 at 5:57 PMConduit Pharmaceuticals: Stellar Management Team, New Business Modelseekingalpha.com - February 28 at 12:13 AMConduit Pharmaceuticals Inc. (CDT)sg.finance.yahoo.com - February 15 at 7:09 AMConduit Pharmaceuticals Inc. (CDTTW)uk.finance.yahoo.com - February 13 at 8:56 AMConduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - January 31 at 10:26 AMConduit Pharmaceuticals Inc.wsj.com - December 6 at 5:58 AMConduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conferencefinance.yahoo.com - November 2 at 9:39 AMKXIN and ICU among pre-market losersmsn.com - October 31 at 9:20 AMConduit Pharma (NASDAQ: CDT), that disaster of a despac, up 80% on speculationdhakatribune.com - October 30 at 8:26 AMCDT Conduit Pharmaceuticals Inc.seekingalpha.com - October 28 at 11:39 PMConduit Pharmaceuticals Inc (CDT)uk.investing.com - October 24 at 8:47 AMConduit Pharma CEO Tapolczay on Biopharma Differentiation, Pipelinefinance.yahoo.com - October 11 at 11:54 AMConduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656finance.yahoo.com - October 11 at 11:54 AMMedia Sentiment Over TimeCompany DescriptionsAben MineralsOTCMKTS:ABNAFAben Minerals Ltd. engages in the acquisition and exploration of mineral properties primarily in British Columbia, Saskatchewan, and Yukon, Canada. The company primarily explores for gold and graphite deposits. Its flagship project is the Forrest Kerr Gold project that covers an area of 23,397 hectares located in northwestern British Columbia. The company was formerly known as Aben Resources Ltd. and changed its name to Aben Minerals Ltd. in February 2023. Aben Minerals Ltd. was incorporated in 1960 and is headquartered in Vancouver, Canada.Toubani ResourcesOTCMKTS:AGGFFToubani Resources Inc. engages in the exploration and development of gold properties in West Africa. It focuses on the Kobada Gold project located in Southern Mali. The company was formerly known as African Gold Group, Inc. and changed its name to Toubani Resources Inc. in June 2022. Toubani Resources Inc. was incorporated in 2002 and is headquartered in Toronto, Canada.Alacer GoldOTCMKTS:ALIAFAlacer Gold Corp. engages in the mining, development, and exploration of mineral deposits in Turkey. It primarily holds an 80% interest in the Ãöpler gold mine that is located in the Erzincan Province, east-central Turkey. The company was incorporated in 1993 and is based in Denver, Colorado.Conduit PharmaceuticalsNASDAQ:CDTConduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.